| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
Journal of the American Society of Nephrology, Vol 6, 257-263, Copyright © 1995 by American Society of Nephrology
REGULAR ARTICLES |
F Gaspari, N Perico, P Ruggenenti, L Mosconi, CS Amuchastegui, E Guerini, E Daina and G Remuzzi
Mario Negri Institute for Pharmacological Research, Bergamo, Italy.
Renal clearance of inulin is the best available indicator of GFR but cannot be used routinely for clinical purposes and is also difficult to perform for clinical investigation when repeated measurements are required. The aim of this study was to find a reliable alternative to inulin clearance that would allow one to avoid the use of radioactivity and problems related to the continuous infusion of the marker. The plasma clearance of unlabeled iohexol, a nonionic contrast agent, was used. Forty-one patients (creatinine clearance 6 to 160 mL/min per 1.73 m2) underwent simultaneous measurements of renal clearance of inulin and plasma clearance of iohexol. Iohexol was given as a single iv dose, and blood samples were drawn up to 600 min after the administration. Iohexol concentrations (by HPLC) were analyzed by a two-compartment, open-model system. A highly significant correlation between the plasma clearance of iohexol and the renal clearance of inulin over a wide range of GFR values was found. By analyzing the data with a simplified method that uses a one-compartment model corrected with the Brochner- Mortensen formula, an excellent correlation with the inulin clearance was also observed. When only patients with moderate to severe renal failure were considered, a significant correlation between the two methods was found. A further comparison between GFR determined with iohexol and iopromide, a new low-osmolarity, low-viscosity contrast medium, was also performed in a subgroup of patients.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
N. J Bird, C. Peters, A R. Michell, and A M. Peters Reproducibilities and responses to food intake of GFR measured with chromium-51-EDTA and iohexol simultaneously and independently in normal subjects Nephrol. Dial. Transplant., June 1, 2008; 23(6): 1902 - 1909. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Essig, B. Escoubet, D. de Zuttere, F. Blanchet, F. Arnoult, E. Dupuis, C. Michel, F. Mignon, F. Mentre, C. Clerici, et al. Cardiovascular remodelling and extracellular fluid excess in early stages of chronic kidney disease Nephrol. Dial. Transplant., January 1, 2008; 23(1): 239 - 248. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Cattaneo, M. Cortinovis, S. Baldelli, A. Bitto, E. Gotti, G. Remuzzi, and N. Perico Pharmacokinetics of Mycophenolate Sodium and Comparison with the Mofetil Formulation in Stable Kidney Transplant Recipients Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1147 - 1155. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sarapa, P. Wickremasingha, N. Ge, R. Weitzman, M. Fuellhart, C. Yen, and J. Lloyd-Parks Lack of Effect of DX-619, a Novel Des-Fluoro(6)-Quinolone, on Glomerular Filtration Rate Measured by Serum Clearance of Cold Iohexol Antimicrob. Agents Chemother., June 1, 2007; 51(6): 1912 - 1917. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Noris, F. Casiraghi, M. Todeschini, P. Cravedi, D. Cugini, G. Monteferrante, S. Aiello, L. Cassis, E. Gotti, F. Gaspari, et al. Regulatory T Cells and T Cell Depletion: Role of Immunosuppressive Drugs J. Am. Soc. Nephrol., March 1, 2007; 18(3): 1007 - 1018. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Boss, P. Martirosian, M. Gehrmann, F. Artunc, T. Risler, N. Oesingmann, C. D. Claussen, F. Schick, K. Kuper, and H.-P. Schlemmer Quantitative Assessment of Glomerular Filtration Rate with MR Gadolinium Slope Clearance Measurements: A Phase I Trial Radiology, March 1, 2007; 242(3): 783 - 790. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Traynor, R. Mactier, C. C Geddes, and J. G Fox How to measure renal function in clinical practice. BMJ, October 7, 2006; 333(7571): 733 - 737. [Full Text] [PDF] |
||||
![]() |
L. Antiga, M. Piccinelli, G. Fasolini, B. Ene-Iordache, P. Ondei, S. Bruno, G. Remuzzi, and A. Remuzzi Computed Tomography Evaluation of Autosomal Dominant Polycystic Kidney Disease Progression: A Progress Report Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 754 - 760. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Parvanova, R. Trevisan, I. P. Iliev, B. D. Dimitrov, M. Vedovato, A. Tiengo, G. Remuzzi, and P. Ruggenenti Insulin resistance and microalbuminuria: a cross-sectional, case-control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretion. Diabetes, May 1, 2006; 55(5): 1456 - 1462. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Caramori, P. Fioretto, and M. Mauer Enhancing the Predictive Value of Urinary Albumin for Diabetic Nephropathy J. Am. Soc. Nephrol., February 1, 2006; 17(2): 339 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Zandi-Nejad, B. M. Brenner, M. Mauer, P. Fioretto, P. Ruggenenti, A. Perna, and G. Remuzzi Preventing Microalbuminuria in Type 2 Diabetes N. Engl. J. Med., February 24, 2005; 352(8): 833 - 834. [Full Text] [PDF] |
||||
![]() |
R. Langer, M. Wang, S. M. Stepkowski, W. W. Hancock, R. Han, P. Li, L. Feng, R. A. Kirken, K. L. Berens, B. Dupre, et al. Selectin Inhibitor Bimosiamose Prolongs Survival of Kidney Allografts by Reduction in Intragraft Production of Cytokines and Chemokines J. Am. Soc. Nephrol., November 1, 2004; 15(11): 2893 - 2901. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Erley, B. D. Bader, E. D. Berger, N. Tuncel, S. Winkler, G. Tepe, T. Risler, and S. Duda Gadolinium-based contrast media compared with iodinated media for digital subtraction angiography in azotaemic patients Nephrol. Dial. Transplant., October 1, 2004; 19(10): 2526 - 2531. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Parvanova, I. Iliev, M. Filipponi, B. D. Dimitrov, M. Vedovato, A. Tiengo, R. Trevisan, G. Remuzzi, and P. Ruggenenti Insulin Resistance and Proliferative Retinopathy: A Cross-Sectional, Case-Control Study in 115 Patients with Type 2 Diabetes J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4371 - 4376. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gotti, N. Perico, A. Perna, F. Gaspari, D. Cattaneo, R. Caruso, S. Ferrari, N. Stucchi, G. Marchetti, M. Abbate, et al. Renal Transplantation: Can We Reduce Calcineurin Inhibitor/Stop Steroids? Evidence Based on Protocol Biopsy Findings J. Am. Soc. Nephrol., March 1, 2003; 14(3): 755 - 766. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. White, R. W. Bilous, S. M. Marshall, M. El Nahas, G. Remuzzi, G. Piras, S. De Cosmo, and G. Viberti Podocyte Number in Normotensive Type 1 Diabetic Patients With Albuminuria Diabetes, October 1, 2002; 51(10): 3083 - 3089. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Bostom, F. Kronenberg, and E. Ritz Predictive Performance of Renal Function Equations for Patients with Chronic Kidney Disease and Normal Serum Creatinine Levels J. Am. Soc. Nephrol., August 1, 2002; 13(8): 2140 - 2144. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ruggenenti, A. Perna, and G. Remuzzi ACE Inhibitors to Prevent End-Stage Renal Disease: When to Start and Why Possibly Never to Stop: A Post Hoc Analysis of the REIN Trial Results J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2832 - 2837. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. PODDER, S. M. STEPKOWSKI, K. L. NAPOLI, J. CLARK, R. R. VERANI, T.-C. CHOU, and B. D. KAHAN Pharmacokinetic Interactions Augment Toxicities of Sirolimus/Cyclosporine Combinations J. Am. Soc. Nephrol., May 1, 2001; 12(5): 1059 - 1071. [Abstract] [Full Text] |
||||
![]() |
The European Study for the Prevention of Renal Dis Effect of 3 Years of Antihypertensive Therapy on Renal Structure in Type 1 Diabetic Patients With Albuminuria: The European Study for the Prevention of Renal Disease in Type 1 Diabetes (ESPRIT) Diabetes, April 1, 2001; 50(4): 843 - 850. [Abstract] [Full Text] |
||||
![]() |
P. Ruggenenti, F. Gaspari, A. Perna, and G. Remuzzi Cross sectional longitudinal study of spot morning urine protein:creatinine ratio, 24 hour urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic renal disease in patients without diabetes BMJ, February 14, 1998; 316(7130): 504 - 509. [Abstract] [Full Text] |
||||
![]() |
W. E. Braselton, K. J. Stuart, and J. M. Kruger Measurement of serum iohexol by determination of iodine with inductively coupled plasma–atomic emission spectroscopy Clin. Chem., August 1, 1997; 43(8): 1429 - 1435. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673